World Health Organization (September 2015).
In September 2015 the World Health Organization (WHO) released early guidelines that highlight two key recommendations: (1) initiating antiretroviral therapy (ART) for every person living with HIV, regardless of CD4 cell count; and (2) using daily oral pre-exposure prophylaxis (PrEP) for individuals at high risk of HIV acquisition. These two recommendations were made available on early-release basis because of their potential to significantly reduce the number of people acquiring HIV infection and dying from HIV-related causes, and to exert a significant effect on global public health. The WHO guidelines target national HIV program managers who will be responsible for adapting the new recommendations at the country level, along with other stakeholders including national tuberculosis program managers, civil society organizations, and domestic and international funders of HIV programs. The full update of the guidelines on using antiretroviral drugs to treat and prevent HIV infection is expected in 2016. It will include comprehensive clinical recommendations and revised operational and service delivery guidance to help support implementation.